A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions

Authors

  • NM. Heddle ART, MSc,

    Diagnostic Unit Manager, Corresponding author
    1. Departments of Pathology, Medicine, and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    2. Transfusion Medicine Service, Chedoke-McMaster Hospitals, Hamilton, Ontario, Canada
    3. Canadian Red Cross Blood Transfusion Service, Hamilton Centre, Hamilton, Ontario, Canada
      Hematology and Transfusion Medicine Service, Chedoke-McMaster Hospitals, Room 2N38, 1200 Main Street West, Hamilton, ON L8N 3Z5, Canada
    Search for more papers by this author
  • LN. Klama,

    1. Departments of Pathology, Medicine, and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    2. Transfusion Medicine Service, Chedoke-McMaster Hospitals, Hamilton, Ontario, Canada
    3. Canadian Red Cross Blood Transfusion Service, Hamilton Centre, Hamilton, Ontario, Canada
    Search for more papers by this author
    • 5

      Luba N. Klama, RT, Research Assistant, Department of Pathology, McMaster University.

  • L. Griffith,

    1. Departments of Pathology, Medicine, and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    2. Transfusion Medicine Service, Chedoke-McMaster Hospitals, Hamilton, Ontario, Canada
    3. Canadian Red Cross Blood Transfusion Service, Hamilton Centre, Hamilton, Ontario, Canada
    Search for more papers by this author
    • 6

      Lauren Griffith, MSc, Research Assistant, Department of Clinical Epidemiology and Biostatistics, McMaster University.

  • R. Roberts,

    1. Departments of Pathology, Medicine, and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    2. Transfusion Medicine Service, Chedoke-McMaster Hospitals, Hamilton, Ontario, Canada
    3. Canadian Red Cross Blood Transfusion Service, Hamilton Centre, Hamilton, Ontario, Canada
    Search for more papers by this author
    • 7

      Robin Roberts, Professor, Department of Clinical Epidemiology and Biostatistics, McMaster University.

  • G. Shukla,

    1. Departments of Pathology, Medicine, and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    2. Transfusion Medicine Service, Chedoke-McMaster Hospitals, Hamilton, Ontario, Canada
    3. Canadian Red Cross Blood Transfusion Service, Hamilton Centre, Hamilton, Ontario, Canada
    Search for more papers by this author
    • 8

      Geeta Shukla, MSc, Research Assistant, Transfusion Medicine Service, Chedoke-McMaster Hospitals.

  • JG. Kelton

    1. Departments of Pathology, Medicine, and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    2. Transfusion Medicine Service, Chedoke-McMaster Hospitals, Hamilton, Ontario, Canada
    3. Canadian Red Cross Blood Transfusion Service, Hamilton Centre, Hamilton, Ontario, Canada
    Search for more papers by this author
    • 9

      John G. Kelton, MD, Director, Transfusion Medicine Service, Chedoke-McMaster Hospitals; Professor, Departments of Pathology and Medicine, McMaster University; and Deputy Director, Canadian Red Cross Blood Transfusion Service, Hamilton, ON.


Hematology and Transfusion Medicine Service, Chedoke-McMaster Hospitals, Room 2N38, 1200 Main Street West, Hamilton, ON L8N 3Z5, Canada

Abstract

It is generally assumed that febrile nonhemolytic transfusion reactions are an immunologically mediated reaction involving the recipient's plasma and the white cells in the donor unit. This has led to the use of white cell reduction and pretransfusion medication, to try to minimize these reactions. To better understand febrile transfusion reactions, a prospective study was performed in which all patients receiving platelet and red cell transfusions in a tertiary-care medical center were interviewed before and after transfusion to obtain information about the typical presentation of the syndrome. It was found that transfusion reactions were much more frequently associated with platelet transfusion (30.8%) than with red cell transfusion (6.8%, p < 0.0005). The routine use of antipyretics prevented most episodes of fever but did not prevent the occurrence of other symptoms such as chills, cold, and discomfort. The application of logistic regression analysis revealed that the dominant factor determining the risk of a reaction was not white cell contamination, but the age of the component (p < 0.005). The significant relationship between reaction and the increasing age of the component suggests that cytokines released in the component during storage may be responsible for many reactions to blood components.

Ancillary